Surely this disparity will disappear when or if PIQ can get the message out there that they have the new bench mark test. Both cost effective and more accurate than what is currently in the offering. It seems like a no brainer but obviously it is extremely difficult to break into new markets. Maybe one of the big Biotecs will buy PIQ out. Sit and wait l guess.
Ann: PromarkerD Intellectual Property portfolio expands, page-21
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
76.0¢ |
Change
-0.010(1.30%) |
Mkt cap ! $99.56M | |||
| Open | High | Low | Value | Volume |
| 77.0¢ | 77.0¢ | 75.3¢ | $271.7K | 355.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 717 | 76.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 77.0¢ | 1298 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |